A Vision for the Future: Reducing the Burden of Anti-VEGF Therapy With Emerging Options

0.75 CME
0.75 ABO MOC
45 MINS
$0 FEE
SAVE
cme

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education


Support Statement

This activity is supported by an educational grant from Genentech, Inc.


Activity Description

Evolving advances for the treatment of neovascular retinal diseases have the potential to further enhance visual acuity outcomes while reducing treatment burden. Several novel delivery systems, along with therapies that target alternate pathways, are currently being evaluated in clinical studies. Understanding these therapeutic advances prior to their possible approval is imperative for their optimal integration into clinical practice. In this educational activity, experts in the field review the burden associated with current treatment strategies in neovascular retinal diseases, investigate the role of subretinal fluid in determining response to treatment, as well as evaluate new and emerging modalities that may reduce the burden of anti-vascular endothelial growth factor (VEGF) therapy in neovascular retinal diseases.


Target Audience

The intended audience for this acitivty is ophthalmologists, retina specialists, and other health care professionals involved in the management of patients with neovascular retinal diseases.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Review the burden associated with current therapies used for the treatment of neovascular retinal diseases.
  • Investigate the role of subretinal fluid in determining response to treatment in neovascular retinal diseases.
  • Evaluate new and emerging modalities that may reduce the burden of anti-VEGF therapy in neovascular retinal diseases.

Activity Chair

Nancy M. Holekamp, MD
Director, Retina Services
Pepose Vision Institute
Professor of Clinical Ophthalmology
Washington University School of Medicine
St. Louis, MO


Faculty

Margaret A. Chang, MD, MS
Senior Partner
Retinal Consultants of Sacramento
Sacramento, CA


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning requirements for the American Board of Ophthalmology’s Maintenance of Certification (ABO MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit. 

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn MOC credits equivalent to the amount of CME credits claimed for the activity. The CME activity provider will submit learner completion information to the ACCME for the purpose of granting ABO MOC credits within 30 days of activity completion.

This enduring material is approved for 1 year from the date of original release, October 30, 2020, through October 29, 2021.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.

Activity Chair and Faculty report the following relationship(s)

Margaret A. Chang, MD, MS
Consulting Fee: Genentech

Nancy M. Holekamp, MD
Intellectual Property/Patent: Katalyst Surgical
Consulting Fee: Acucela, Allergan, Clearside, Gemini, Genentech, Gyroscope, Katalyst Surgical, Lineage Cell Therapeutics, Notal Vision, Novartis, Regeneron
Speakers Bureau: Allergan, Genentech, Novartis, Regeneron, Spark Therapeutics
Contracted Research: Gemini, Genentech, Gyroscope
Ownership Interest: Katalyst Surgical

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com